Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07161713 · ClinicalTrials.gov registry record · NA
SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors
A NA study of Lung Adenocarcinoma and NHL, sponsored by Barbara Nemesure.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07161713: Recruiting NA study of Lung Adenocarcinoma and NHL, sponsored by Barbara Nemesure.
NCT07161713 is a NA study of Lung Adenocarcinoma and NHL that is actively recruiting participants, run by Barbara Nemesure. The registered enrollment target is 100 participants, below the 552-participant average among 14 other Lung Adenocarcinoma trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07161713, a NA study of Lung Adenocarcinoma and NHL, is actively recruiting participants, sponsored by Barbara Nemesure.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Cancer survivors can experience health issues that cause chronic illness and lower quality of life. Yoga is a well-known holistic approach to health and overall well-being. Mindfulness has many benefits, including improved focus and less stress. This study aims to evaluate if yoga and/or mindfulness has a positive effect on cancer survivors social, emotional and physical well-being as well as their epigenetics. Epigenetics is how the environment can effect your genes; not by changing our DNA, but by turning genes on or off.
Primary Outcome
Patient reported quality of life measured using the validated quality of life questionnaire C30 (QLQ-C30), developed by the European Organisation for Research and Treatment of Cancer. This scale includes 5 functional and 3 symptom scales, each scored as a 0-100 scale, where higher scores indicate a better outcome on functional scales and global health status, and a worse outcome on symptoms.
Conditions Studied
Interventions
- BEHAVIORAL Oncology-informed yoga
- BEHAVIORAL SMART
Study Locations (1)
New York
- Stony Brook University Cancer Center - Stony Brook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-09-17 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
What NCT07161713 shows while recruiting
NCT07161713 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 552-participant average among 14 other Lung Adenocarcinoma trials with a reported enrollment target (82% lower).
The record links to 10 conditions, with Lung Adenocarcinoma appearing as the primary indexed condition, and to 2 interventions - of which Oncology-informed yoga is the first listed.
NCT07161713 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07161713 about?
NCT07161713 is a clinical study titled "SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors". Cancer survivors can experience health issues that cause chronic illness and lower quality of life. Yoga is a well-known holistic approach to health and overall well-being. Mindfulness has many benefits, including improved focus and less stress. This study aims to evaluate if yoga and/or mindfulness...
What is the current status of trial NCT07161713?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-09-17. Estimated completion is 2027-09-30.
What conditions does trial NCT07161713 study?
This clinical trial studies the following conditions: Lung Adenocarcinoma, NHL, Lung Cancer (Diagnosis), Lung Adenocarcinoma Metastatic, Lung Adenocarcinoma Stage IIIB/IV.
What interventions are being tested in trial NCT07161713?
The interventions under investigation include: Oncology-informed yoga (BEHAVIORAL), SMART (BEHAVIORAL).
Who is sponsoring clinical trial NCT07161713?
This trial is sponsored by Barbara Nemesure, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07161713 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Adenocarcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07161713's enrollment target sits among peer trials
100 9th of 14 higher than 6 of 14 other Lung Adenocarcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Adenocarcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Engagement of Veterans With Lung Cancer
RECRUITING · NA
-
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer
RECRUITING · NA
-
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RECRUITING · Phase 1
-
An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer
RECRUITING · Phase 1
-
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
RECRUITING · Phase 2
-
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI